Hadi Younes, MD (@SinusAtria) profile picture

Cardiac EP - PGY-2 IM @EmoryDeptofMed - Alumnus @TulaneTRIAD - Editorial Board Member @BioMedCentral Cardiovascular Disorders - Peer Reviewer #HRS #JAHA #JICE

Atlanta, GA
Joined January 2020
Photo by Hadi Younes, MD (@SinusAtria)Photo by Hadi Younes, MD (@SinusAtria)Photo by Hadi Younes, MD (@SinusAtria)Photo by Hadi Younes, MD (@SinusAtria)Photo by Hadi Younes, MD (@SinusAtria)Photo by Hadi Younes, MD (@SinusAtria)Photo by Hadi Younes, MD (@SinusAtria)Photo by Hadi Younes, MD (@SinusAtria)Photo by Hadi Younes, MD (@SinusAtria)Photo by Hadi Younes, MD (@SinusAtria)
Hadi Younes, MD retweeted
For nearly 20 years, our teams have worked to understand #AFib through the biology of the #atrial substrate. What began as a hypothesis around atrial fibrosis is becoming increasingly clear. The question may no longer be simply: PVI versus substrate ablation? The more important question is: Which AF patient has a modifiable atrial substrate, where is it, and can we reliably eliminate it? DECAAF I established that atrial fibrosis matters and strongly predicts ablation outcome. DECAAF II then tested MRI-guided fibrosis ablation in persistent AF. The overall trial was neutral, but the mechanistic lesson was important: identifying fibrosis alone was not enough. Intended ablation did not always translate into durable scar, and benefit appeared related to both disease extent and effective substrate coverage. IDEAL-AF and COAST-AF now add another piece. IDEAL-AF selected only patients with meaningful low-voltage substrate for randomization. When that substrate was specifically targeted with clear electrical endpoints, outcomes improved substantially over PVI alone. COAST-AF tells a similar story. The overall trial was negative, but among patients who actually had low-voltage areas, substrate ablation significantly improved outcomes. Patients without demonstrable substrate did not appear to benefit. These studies may therefore be defining the same biology from different directions: No significant atrial substrate → PVI may be enough. A demonstrable, modifiable atrial myopathy → PVI alone may be inadequate. Advanced, diffuse disease → simply adding more ablation may not overcome the biology. The next phase of AF ablation should move beyond “more ablation” toward precision substrate therapy: identify the AF fibrosis/myopathy phenotype, select the right patient, define the abnormal tissue accurately, and ensure that it is truly modified or isolated. The future is not empiric substrate ablation. It is targeting the AF substrate in the right patient, at the right stage of disease. @chris_sohns @PrashSanders @peterkistler3 @S_NarayanMD @Phiso_de @netta_doc @TinaBaykaner @DrRoderickTung @Ed_Gerst @shivkumarmd @Siddmann @gautamsand @drjohnm @TulaneTriad
Presented at #ScientificSessions26: In a prespecified principal subgroup of patients with low-voltage areas, adjunctive low-voltage area ablation with pulmonary vein isolation was associated with lower atrial arrhythmia recurrence and lower atrial fibrillation burden than pulmonary vein isolation alone. These findings indicate that substrate-guided ablation may have relevance for treatment selection in patients with persistent #AtrialFibrillation who have low-voltage areas identified during mapping. ja.ma/4iFimDE
3
38
2
97
16,897
Hadi Younes, MD retweeted
New DEEP-PFA RCT: for EP-led PFA sedation, flurbiprofen + midazolam/fentanyl achieved 83.8% effective sedation with 7.5% hypoxemia and 6.2% hypotension—a practical efficacy/safety balance. Great to collaborate with Drs. Song Zuo, Changsheng Ma & team from An Zhen Hospital.
Electrophysiologist-Led Deep Sedation for Pulsed Field Ablation of Atrial Fibrillation Using a Bipolar Contact Force Focal Catheter: The DEEP-PFA Randomized Controlled Trial @paulzei @HanFengGHD #Epeeps ahajrnls.org/4e4Vo7z
1
1
127
Hadi Younes, MD retweeted
One strip a week, make long term AF monitoring easier and less burden to patients. Great work from @YingshuoL and the team! #SevereSinus #BenignSinus @TulaneTriad @Tulane_Heart @TulaneMedicine @MassadChristian @BidaouiGhassan @YishiJia @SinusAtria
Severe or Benign Sinus? AI reclassifies 30-second single-lead ECGs around documented AF recurrence with AUC 0.86. @chanholim @HanFengGHD @AmitabhCPandey @nmarrouche #Epeeps doi.org/10.1161/CIRCEP.125.0…
2
2
200
Hadi Younes, MD retweeted
New lesson from DECAAF II led by @YingshuoL : SR near AF is not the same as SR without no AF—like the body after exercise, the ECG may look “at rest” while physiology still carries a recovery signature. A weekly strip may flag a missed episode for a week. ovid.com/jnls/circep/fulltex…
2
3
2
7
1,938
Hadi Younes, MD retweeted
#ResistTheUrge to ablate more
Proud of our TRIAD fellow Michel Abou Khalil @mabou_khalil for this important work in JCE! In nearly 19,000 patients undergoing first ablation for paroxysmal #AFib, adding lesions beyond PVI was associated with more recurrence, repeat ablation, and atypical flutter. An observational study, but an important reminder: more ablation does not necessarily mean better outcomes. Defining when—and for whom—to go beyond PVI remains critical. @PrashSanders @Dr_Santangeli @S_NarayanMD @shivkumarmd @TinaBaykaner @JonHsuMD @peterkistler3 @DocOfHearts @drjohnm @EJSMD @AndreaRussoEP @Phiso_de @DrJasonAndrade
3
6
21
8,423
Hadi Younes, MD retweeted
Proud of our TRIAD fellow Michel Abou Khalil @mabou_khalil for this important work in JCE! In nearly 19,000 patients undergoing first ablation for paroxysmal #AFib, adding lesions beyond PVI was associated with more recurrence, repeat ablation, and atypical flutter. An observational study, but an important reminder: more ablation does not necessarily mean better outcomes. Defining when—and for whom—to go beyond PVI remains critical. @PrashSanders @Dr_Santangeli @S_NarayanMD @shivkumarmd @TinaBaykaner @JonHsuMD @peterkistler3 @DocOfHearts @drjohnm @EJSMD @AndreaRussoEP @Phiso_de @DrJasonAndrade
Out now in JCE: is more ablation better in paroxysmal AF? 18,891 pts, 27% got PVI+ at first ablation. After matching, PVI+ led to: ↑ Recurrence (HR 1.28) ↑ Redo ablation (HR 1.99) ↑ Atypical flutter (HR 2.63) ↑ Persistent AF (HR 1.37) doi.org/10.1111/jce.70519 @nmarrouche
3
18
1
42
10,180
Hadi Younes, MD retweeted
Out now in JCE: is more ablation better in paroxysmal AF? 18,891 pts, 27% got PVI+ at first ablation. After matching, PVI+ led to: ↑ Recurrence (HR 1.28) ↑ Redo ablation (HR 1.99) ↑ Atypical flutter (HR 2.63) ↑ Persistent AF (HR 1.37) doi.org/10.1111/jce.70519 @nmarrouche
9
2
14
3,959
Hadi Younes, MD retweeted
Exciting discussion about optimizing conduction system pacing! “We still struggle with a unified consensus definition of left bundle area capture” #hrx2026 @HRSonline @melchami99 @danealson @FaisalMMerchant @emoryhealthcare @NinoIsakadze
1
4
8
650
Hadi Younes, MD retweeted
Honored to have the great @PrashSanders talk to us about practical ways to address risk factor modification for our pts w/ AF. at @EmoryUniversity @emoryhealthcare @melchami99 @danealson @FaisalMMerchant @AnandShah_MD @HRSonline @HeartRhythmTV @np_varghese
3
11
437
Hadi Younes, MD retweeted
Honored to present our team’s work at #HRX2026! Always inspiring to see innovations and meet people. Two takeaways from this: 1️⃣ Move beyond baseline and fixed-window prediction to world model. 2️⃣ Treatment during the AF blanking period may offer opportunities for optimization.
2
7
9
486
Hadi Younes, MD retweeted
Updates from CASTLE-HFpEF at #GlobalEPSummit2026 ⚡️ @nmarrouche presenting the latest on AF ablation in HFpEF — an important frontier at the intersection of #AFib and #HeartFailure. Great discussion in Cleveland! @ccfcards #EPeeps
3
20
1,812
Hadi Younes, MD retweeted
Proud of @mabou_khalil !!
Honored to present at #HRX26 on why income matters in both research and clinical practice. In the HEARTBEAT study, lower-income patients in Louisiana had worse biometric profiles and more CV events compared with higher-income patients. @TulaneTriad @nmarrouche @HanFengGHD
3
10
1,593
Hadi Younes, MD retweeted
Very important message from our group. In patients with recurrent AF after a first ablation, what we do next matters. Repeat catheter ablation was associated with a 35% lower risk of death, stroke, or HF hospitalization compared with cardioversion, with an NNT of only 14. This challenges the idea that management of recurrent AF should simply be based on operator preference. Recurrence after ablation should not be viewed as failure—it may be an opportunity to intervene again and improve meaningful clinical outcomes. Congratulations to @mabou_khalil @HanFengGHD @QMarashly and the entire team. #AFib #Ablation #EPeeps @PrashSanders @shivkumarmd @gautamsand @S_NarayanMD @Phiso_de @drsuneet @drjohnm @drluissaenz @leftbundle @KennethEllenbo1 @DrBradleyKnight @DrRoderickTung @atulverma_md
3
23
60
11,619
Hadi Younes, MD retweeted
As a junior investigator, #WesternAFib is a valuable chance to broaden how I think about AFib. Not necessarily to reach consensus, but to understand the different perspectives, uncertainties, and tradeoffs that shape the field.
3
8
428
Hadi Younes, MD retweeted
Replying to @ReddyEPS
Madhu Reddy, MD, on what sets Western AFib apart: a focused setting for open discussion of important—and sometimes controversial—topics. Lock in our lowest rates and use code AWARENESS for an extra $100 off: hubs.ly/Q04xgS2K0 #WAFIB2027 @nmarrouche @EPLabDigest
1
3
7
1,187
Hadi Younes, MD retweeted
Loved meeting and spending time with @IsmaelSaibari ! Impressive human being and great addition to @FCBayern
1
1
10
756
Hadi Younes, MD retweeted
Met the legend @LMatthaeus10 today! Love hearing his vision for German football!! @Phiso_de @FCBayern @chris_sohns
4
16
700